The Successful Application of Plasmapheresis in the Treatment of a Patient with Opsoclonus and Autoantibodies to Glutamate Receptor δ2-Reference-Cited by-同舟云学术

The Successful Application of Plasmapheresis in the Treatment of a Patient with Opsoclonus and Autoantibodies to Glutamate Receptor δ2

Published:2017 Issue:20 Volume:56 Page:2773-2778
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Nakamagoe Kiyotaka¹,Nohara Seitaro¹,Takahashi Yukitoshi²,Takiguchi Mao¹,Kawakami Rio¹,Koganezawa Tadachika³,Tamaoka Akira¹

Affiliation:

1. Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan

2. National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Japan

3. Department of Physiology, Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/20/56_6771-15/_pdf

Reference25 articles.

1. 1. Zee Ds, Robinson Da. A hypothetical explanation of saccadic oscillations. Ann Neurol 5: 405-414, 1979.

2. 2. Wong AM, Musallam S, Tomlinson RD, Shannon P, Sharpe JA. Opsoclonus in three dimensions: oculographic, neuropathologic and medelling correlates. J Neurol Sci 189: 71-81, 2001.

3. 3. Helmchen C, Rambold H, Sprenger A, Erdmann C, Binkofski F. Cerebellar activation in opsoclonus: an fMRI study. Neurology 61: 412-415, 2003.

4. 4. Helmchen C, Rambold H, Erdmann C, Mohr C, Sprenger A, Binkofski F. The role of the fastigial nucleus in saccadic eye oscillations. Ann N Y Acad Sci 1004: 229-240, 2003.

5. 5. Jen JC, Lopez I, Baloh RW. Opsoclonus: clinical and immunological features. J Neurol Sci 320: 61-65, 2012.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose transporter type 1 deficiency syndrome associated with autoantibodies to glutamate receptors;Brain and Development;2020-10

2. Nonparaneoplastic autoimmune cerebellar ataxias;Current Opinion in Neurology;2019-06